drug

quizartinib

1 story · latest Nov 9, 2026

Follow quizartinib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2023 · NDA216993
Brand: Vanflyta

Relationships

Developed by Daiichi Sankyo

Timeline

Tango reports pancreatic cancer combo data, plans Phase 3 start in 1H 2027

Nov 9Quarterly updateKura Oncology, Inc.Tango Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.